Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07229365 · ClinicalTrials.gov registry record · NA

Children's Viewing Behavior

A NA study of Myopia and Juvenile Myopia, sponsored by SightGlass Vision.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT07229365: Recruiting NA study of Myopia and Juvenile Myopia, sponsored by SightGlass Vision.

NCT07229365 is a NA study of Myopia and Juvenile Myopia that is actively recruiting participants, run by SightGlass Vision. The registered enrollment target is 20 participants, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07229365, a NA study of Myopia and Juvenile Myopia, is actively recruiting participants, sponsored by SightGlass Vision.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to investigate the area of the spectacle lens in which a subject is viewing through regardless of task being performed.

Interventions

  • DEVICE Novel spectacle lens design
  • DEVICE Spectacle lenses

Study Locations (1)

Indiana

  • Indiana University - Bloomington

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-12-22
Est. Completion 2026-07-01
Phase NA
SightGlass Vision

8 total trials

What NCT07229365 shows while recruiting

NCT07229365 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Novel spectacle lens design is the first listed.

NCT07229365 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT07229365 about?

NCT07229365 is a clinical study titled "Children's Viewing Behavior". The aim of this study is to investigate the area of the spectacle lens in which a subject is viewing through regardless of task being performed.

What is the current status of trial NCT07229365?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-12-22. Estimated completion is 2026-07-01.

What conditions does trial NCT07229365 study?

This clinical trial studies the following conditions: Myopia, Juvenile Myopia, Myopia Progression.

What interventions are being tested in trial NCT07229365?

The interventions under investigation include: Novel spectacle lens design (DEVICE), Spectacle lenses (DEVICE).

Who is sponsoring clinical trial NCT07229365?

This trial is sponsored by SightGlass Vision, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07229365 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07229365's enrollment target sits among peer trials

20 88th of 90 higher than 2 of 90 other Myopia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07229365, the US trial registry maintained by the National Library of Medicine. NCT07229365 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.